Clincosm LogoSign in Get a demo

Rheumatoid Arthritis

Showing NaN - NaN of 130
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial in Worldwide (Certolizumab pegol (CZP), Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Certolizumab pegol (CZP)
  • Placebo
  • Birmingham, Alabama
  • +180 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol + Methotrexate (MTX), Placebo + Methotrexate (MTX))

Completed
Has Results
  • Rheumatoid Arthritis
  • Certolizumab Pegol + Methotrexate (MTX)
  • Placebo + Methotrexate (MTX)
  • Birmingham, Alabama
  • +177 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol, Placebo, Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Certolizumab Pegol
  • +2 more
  • Birmingham, Alabama
  • +177 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol (CZP), Adalimumab (ADA), Methotrexate (MTX))

Completed
Has Results
  • Rheumatoid Arthritis
  • Certolizumab Pegol (CZP)
  • +2 more
  • Birmingham, Alabama
  • +174 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Germany, Poland (MR Prednisone, IR Prednisone, Placebo - MR Prednisone)

Completed
Has Results
  • Rheumatoid Arthritis
  • MR Prednisone
  • +3 more
  • Aachen, Germany
  • +23 more
Jun 4, 2018

Rheumatoid Arthritis Trial in Worldwide (LY2127399)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +326 more
May 11, 2018

Rheumatoid Arthritis Trial in Worldwide (PF-06438179, Infliximab)

Completed
Has Results
  • Rheumatoid Arthritis
  • PF-06438179
  • Infliximab
  • Birmingham, Alabama
  • +183 more
Apr 30, 2018

Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q4W, Placebo Q2W)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +200 more
May 11, 2018

Rheumatoid Arthritis Trial in Worldwide (GP2013 - A Proposed biosimilar rituximab, Originator rituximab - Rituxan ® or MabThera

Completed
Has Results
  • Rheumatoid Arthritis
  • GP2013 - A Proposed biosimilar rituximab
  • Originator rituximab - Rituxan ® or MabThera ®
  • Huntsville, Alabama
  • +64 more
Nov 30, 2017

Rheumatoid Arthritis Trial in Berlin, Harrow (AZD9567 10 mg, AZD9567 20 mg, AZD9567 40 mg)

Completed
  • Rheumatoid Arthritis
  • AZD9567 10 mg
  • +8 more
  • Berlin, Germany
  • +1 more
Oct 16, 2017

Rheumatoid Arthritis Trial in Worldwide (Tregalizumab, Placebo)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Paradise Valley, Arizona
  • +83 more
Jul 25, 2017

Rheumatoid Arthritis Trial in Germany (rituximab [MabThera/Rituxan])

Completed
Has Results
  • Rheumatoid Arthritis
  • rituximab [MabThera/Rituxan]
  • Bad Aibling, Germany
  • +50 more
Jul 11, 2017

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, , hydroxychloroquine)

Completed
Has Results
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +195 more
Jul 7, 2017

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Etanercept, Methotrexate)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +256 more
Jun 28, 2017

Rheumatoid Arthritis Trial in Worldwide (Tocilizumab, Placebo to tocilizumab, Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +235 more
Jun 28, 2017

Rheumatoid Arthritis Trial in Worldwide (Etanercept, Tocilizumab)

Completed
Has Results
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +427 more
Jun 13, 2017

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Placebo (for sarilumab), Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +261 more
Jun 27, 2017

Inflammation, Rheumatoid Arthritis Trial in Berlin (NNC0215-0384, )

Completed
  • Inflammation
  • Rheumatoid Arthritis
  • Berlin, Germany
    Novo Nordisk Investigational Site
Feb 23, 2017

Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC109-0012, )

Completed
  • Inflammation
  • Rheumatoid Arthritis
  • Brno, Czech Republic
  • +28 more
Feb 8, 2017

Inflammation, Rheumatoid Arthritis Trial in Berlin, Moscow, Yaroslavl (NNC0114-0006, )

Completed
  • Inflammation
  • Rheumatoid Arthritis
  • Berlin, Germany
  • +4 more
Feb 6, 2017

Inflammation, Rheumatoid Arthritis, Healthy Trial in Berlin (NNC0114-0000-0005, )

Completed
  • Inflammation
  • +2 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Feb 6, 2017

Rheumatoid Arthritis Trial in Worldwide (methotrexate, rituximab [MabThera/Rituxan])

Completed
Has Results
  • Rheumatoid Arthritis
  • Mesa, Arizona
  • +96 more
Sep 14, 2016

Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Placebo, tocilizumab [RoActemra/Actemra])

Completed
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +167 more
Nov 1, 2016

Rheumatoid Arthritis Trial in Worldwide (MLTA3698A, adalimumab, leflunomide)

Completed
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +66 more
Nov 1, 2016

Rheumatoid Arthritis Trial in Worldwide (P38 Inhibitor (4) 150mg, P38 Inhibitor (4) 25mg, P38 Inhibitor (4) 300mg)

Completed
  • Rheumatoid Arthritis
  • P38 Inhibitor (4) 150mg
  • +5 more
  • Birmingham, Alabama
  • +113 more
Nov 1, 2016